2012
DOI: 10.1016/j.healun.2012.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Long-term support with an ambulatory percutaneous paracorporeal artificial lung

Abstract: Background Conventional ECMO is bulky/non-ambulatory and requires multiple blood transfusions. We hypothesized that a percutaneous, paracorporeal artificial lung (PAL) could be established through a single venous cannulation to provide long-term ambulatory respiratory support. Methods Our PAL system was tested in 11 healthy sheep. Avalon Elite™ DLC, inserted through right jugular vein into SVC, RA and IVC, was connected to a CentriMag pump and compact hollow fiber gas exchanger, forming a short circuit PAL s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
19
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 19 publications
1
19
0
Order By: Relevance
“…This design is based on our active patent[28], which has been commercialized as the AvalonElite DLC. The AvalonElite DLC has been successfully applied in extracorporeal membrane oxygenation (ECMO) with proven long term (month) durability and high performance [2931]. The A-Med jugular coaxial cannula was a two separate cannula system with the infusion cannula inside the drainage cannula.…”
Section: Discussionmentioning
confidence: 99%
“…This design is based on our active patent[28], which has been commercialized as the AvalonElite DLC. The AvalonElite DLC has been successfully applied in extracorporeal membrane oxygenation (ECMO) with proven long term (month) durability and high performance [2931]. The A-Med jugular coaxial cannula was a two separate cannula system with the infusion cannula inside the drainage cannula.…”
Section: Discussionmentioning
confidence: 99%
“…Our previous patented ECMO DLC (Avalon Elite ™ , Rancho Dominguez, CA) has successfully proved this concept. 21 The AvalonElite DLC-ECMO circuit is much shorter with much lower resistance than the ECMO circuit with two single lumen cannulas. The AvalonElite DLC spares the femoral vein, enabling patient ambulation.…”
Section: Discussionmentioning
confidence: 99%
“…The CO 2 removal was calculated by multiplying the sweep gas flow rate and the outlet CO 2 concentration. The O 2 transfer was calculated according to the following formula 21 : Oitalic2transfer=1.34×hemoglobin×10×ΔOitalic2sat×Qb+0.003×ΔitalicPO2×Q. Where ΔO 2 sat and ΔPO 2 were the change in blood O 2 saturation and in oxygen pressure across the gas exchange device, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Patients ambulating on traditional ECMO require assistance by a team of nurses, perfusionists, and physical therapists during ambulation. Innovative ambulatory ECMO solutions are on the horizon, however, with encouraging results in animal studies . These devices—often referred to as “artificial lungs”—are compact and are specifically designed for mobility and long‐term use.…”
Section: Introductionmentioning
confidence: 99%